Bliss GVS Pharma informs about credit rating

08 Apr 2026 Evaluate
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed that ICRA vide its letter dated April 08, 2026, bearing ref. no. ICRA/Bliss GVS Pharma Limited/08042026/1 has taken ‘[ICRA]A-(Stable)/ [ICRA]A2+ for Long-term/Short-term - Fund based/Non-fund-based facilities of the Company.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

252.65 16.00 (6.76%)
08-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.60
Dr. Reddys Lab 1191.45
Cipla 1215.80
Zydus Lifesciences 891.55
Lupin 2293.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×